These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis. Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058 [TBL] [Abstract][Full Text] [Related]
3. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Finco O; Frigimelica E; Buricchi F; Petracca R; Galli G; Faenzi E; Meoni E; Bonci A; Agnusdei M; Nardelli F; Bartolini E; Scarselli M; Caproni E; Laera D; Zedda L; Skibinski D; Giovinazzi S; Bastone R; Ianni E; Cevenini R; Grandi G; Grifantini R Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9969-74. PubMed ID: 21628568 [TBL] [Abstract][Full Text] [Related]
4. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen. Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689 [TBL] [Abstract][Full Text] [Related]
5. Antibodies to Variable Domain 4 Linear Epitopes of the Collar AL; Linville AC; Core SB; Wheeler CM; Geisler WM; Peabody DS; Chackerian B; Frietze KM mSphere; 2020 Sep; 5(5):. PubMed ID: 32968007 [No Abstract] [Full Text] [Related]
6. Th1/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection With Nguyen NDNT; Guleed S; Olsen AW; Follmann F; Christensen JP; Dietrich J Front Immunol; 2021; 12():790463. PubMed ID: 34925371 [TBL] [Abstract][Full Text] [Related]
7. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Pal S; Theodor I; Peterson EM; de la Maza LM Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798 [TBL] [Abstract][Full Text] [Related]
9. A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice. Tu J; Hou B; Wang B; Lin X; Gong W; Dong H; Zhu S; Chen S; Xue X; Zhao KN; Zhang L Acta Biochim Biophys Sin (Shanghai); 2014 May; 46(5):401-8. PubMed ID: 24681882 [TBL] [Abstract][Full Text] [Related]
10. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Eko FO; Lubitz W; McMillan L; Ramey K; Moore TT; Ananaba GA; Lyn D; Black CM; Igietseme JU Vaccine; 2003 Apr; 21(15):1694-703. PubMed ID: 12639492 [TBL] [Abstract][Full Text] [Related]
11. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research. Wen Z; Boddicker MA; Kaufhold RM; Khandelwal P; Durr E; Qiu P; Lucas BJ; Nahas DD; Cook JC; Touch S; Skinner JM; Espeseth AS; Przysiecki CT; Zhang L BMC Microbiol; 2016 Jul; 16(1):165. PubMed ID: 27464881 [TBL] [Abstract][Full Text] [Related]
12. Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine. Karunakaran KP; Yu H; Jiang X; Chan Q; Moon KM; Foster LJ; Brunham RC Vaccine; 2015 Apr; 33(18):2159-66. PubMed ID: 25738816 [TBL] [Abstract][Full Text] [Related]
13. Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin. Cheng C; Bettahi I; Cruz-Fisher MI; Pal S; Jain P; Jia Z; Holmgren J; Harandi AM; de la Maza LM Vaccine; 2009 Oct; 27(44):6239-46. PubMed ID: 19686693 [TBL] [Abstract][Full Text] [Related]
15. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522. Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176 [TBL] [Abstract][Full Text] [Related]
16. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines. He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464 [TBL] [Abstract][Full Text] [Related]
17. Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice. Dixit S; Singh SR; Yilma AN; Agee RD; Taha M; Dennis VA Nanomedicine; 2014 Aug; 10(6):1311-21. PubMed ID: 24602605 [TBL] [Abstract][Full Text] [Related]
18. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Igietseme JU; Murdin A Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798 [TBL] [Abstract][Full Text] [Related]